Puma Biotechnology
PBYI
PBYI
133 hedge funds and large institutions have $274M invested in Puma Biotechnology in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 36 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $394M → $274M (-$119M)
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
133
Holding in Top 10
–
Calls
$6.83M
Puts
$6.21M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$4.74M | |
| 3 | +$4.29M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4M |
| 5 |
DM
Deerfield Management
New York
|
+$3.47M |
Top Sellers
| 1 | -$39.7M | |
| 2 | -$15.3M | |
| 3 | -$9.3M | |
| 4 |
O
OrbiMed
New York
|
-$6.85M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.32M |